Ftse Mib
36.109,89
-0,99%
DAX
21.379,64
-1,53%
S&P 500
6.040,53
-0,50%
NASDAQ
19.627,44
0,00%
Bitcoin
94.879,20
-2,88%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Tevogen Bio Holdings Inc (TVGN) Tevogen Bio Holdings Inc (TVGN) Notizie

Tevogen Bio Holdings Inc

TVGN
1,405
-0,085 (-5,70%)
Pre Mercato
Ultimo aggiornamento: 14:06:57
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
28/1/202521:49GLOBETevogen Bio Enters Agreement to Receive Up To $10 Million of..
27/1/202520:24GLOBETevogen Bio CEO Congratulates Lynne Patton on Being..
24/1/202523:34GLOBETevogen Bio Broadens Relationship with Microsoft to Deepen..
24/1/202501:53GLOBETevogen Bio Highlights the Future of AI-Driven Drug..
26/12/202418:21GLOBETevogen Bio to Host Panel Discussions “AI In Biopharma: Next..
23/12/202415:38GLOBETevogen Bio to Host Panel "AI In Biopharma: Next Frontier of..
19/12/202414:30GLOBETevogen Bio Strengthens Robust IP Portfolio With Filing of..
17/12/202419:32GLOBETevogen Bio to Host Panel “Pioneering the Economics of..
10/12/202421:13GLOBETevogen Bio to Attend the 43rd Annual J.P. Morgan Healthcare..
05/12/202417:03GLOBEDr. Ryan Saadi Commends Individuals Who Dedicate Time to..
26/11/202414:05GLOBETevogen Bio Prepares Organizational Readiness to Support..
21/11/202421:59GLOBETevogen Bio CEO Reflects on Public Support, Reaffirms..
19/11/202422:50GLOBETevogen Bio Reports Third Quarter 2024 Financial Results;..
14/11/202423:00GLOBEUPDATE - Tevogen Founder Reflects on Importance of..
14/11/202421:49GLOBETevogen Founder Reflects on Importance of Preserving..
08/11/202421:36GLOBETevogen Bio Nears Finalization of Agreement to Enhance R&D..
05/11/202422:43GLOBETevogen Bio CEO Dr. Ryan Saadi Expresses Gratitude for..
05/11/202415:27GLOBETevogen Bio Leverages Microsoft Partnership to Deliver..
04/11/202420:36GLOBETevogen Bio Announces Appointment of Anthony Tarantino as..
31/10/202415:54GLOBETevogen Bio Expands on Microsoft Partnership to Integrate..
29/10/202420:28GLOBETevogen Bio Reports Nasdaq Listing Compliance as CEO..
29/10/202417:43GLOBETevogen Bio Signs Letter of Intent With CD8 Technology to..
25/10/202423:34GLOBETevogen Bio Provides Additional Guidance on Introduction of..
23/10/202414:35GLOBETevogen Bio’s Effort in Artificial Intelligence, Tevogen AI,..
22/10/202420:30GLOBETevogen Bio To Provide Timelines Associated with Recently..
21/10/202421:58GLOBETevogen Bio Specialty Care Reports Top-Line Revenue Forecast..
21/10/202419:56GLOBETevogen Bio Provides Clarity on CSO Share Sales to Satisfy..
19/10/202404:46GLOBETevogen CEO Expresses Gratitude for Unprecedented Public..
17/10/202415:32GLOBETevogen Bio Oncology Reports Top-Line Revenue Forecast of $1..
17/10/202413:54GLOBETevogen Investors Congratulate on Prestigious Recognition of..
16/10/202422:30GLOBETevogen Bio Thanks Warren Township for Proclamation Honoring..
15/10/202420:30GLOBETevogen Bio Takes Lead in Developing Cell Therapies Designed..
15/10/202417:36GLOBETevogen Bio Highlights the Publication of Promising Trial..
15/10/202400:43GLOBETevogen CEO Reaffirms the Company’s Commitment to Closing..
11/10/202421:59GLOBETevogen Bio Plans to Share $1B+ Revenue Potential of its..
11/10/202418:12GLOBETevogen Bio Extends Pipeline Prioritizing Oncology and Long..
08/10/202420:40GLOBETevogen Bio Highlights Promising Trial Data as CEO Leads..
24/9/202417:09GLOBETevogen Bio Leadership Meets Members of U.S. Congress to..
26/8/202422:10EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
26/8/202422:05EDGAR2Form 8-K/A - Current report: [Amend]
23/8/202423:04EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
23/8/202423:02EDGAR2Form 8-K - Current report
22/8/202415:00GLOBETevogen Bio Secures $6 Million Series C Preferred Stock..
15/8/202418:17GLOBECORRECTION – Tevogen Bio Reports Second Quarter 2024..
15/8/202415:00GLOBETevogen Bio Reports Second Quarter 2024 Financial Results,..
14/8/202422:40EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/8/202422:38EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202415:00GLOBETevogen Bio’s Innovation and Public Health Advisory Board..
09/8/202417:00GLOBETevogen Bio’s Founding CEO, Ryan Saadi, Expresses Conviction..
11/7/202418:21GLOBETevogen Bio Issues Letter to Stockholders Highlighting..
Apertura: Min: Max:
Chiusura: 1,49

La tua Cronologia

NASDAQ
TVGN
Tevogen Bio
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci